Jia Xin Yee
Overview
Explore the profile of Jia Xin Yee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalimuddin S, Tham C, Chan Y, Hang S, Kunasegaran K, Chia A, et al.
Nat Microbiol
. 2025 Jan;
10(2):374-387.
PMID: 39794472
T cells have been identified as correlates of protection in viral infections. However, the level of vaccine-induced T cells needed and the extent to which they alone can control acute...
2.
Mok D, Tng D, Yee J, Chew V, Tham C, Ooi J, et al.
EMBO Mol Med
. 2024 May;
16(6):1310-1323.
PMID: 38745062
Vaccination has successfully controlled several infectious diseases although better vaccines remain desirable. Host response to vaccination studies have identified correlates of vaccine immunogenicity that could be useful to guide development...
3.
Ong E, Koh C, Tng D, Ooi J, Yee J, Chew V, et al.
Med
. 2023 Apr;
4(6):353-360.e2.
PMID: 37105176
Background: Post-mRNA vaccination-associated cardiac complication is a rare but life-threatening adverse event. Its risk has been well balanced by the benefit of vaccination-induced protection against severe COVID-19. As the rate...
4.
Yee J, Kim J, Yeom J
J Microbiol
. 2023 Feb;
61(3):331-341.
PMID: 36800168
Antibiotic treatment failure threatens our ability to control bacterial infections that can cause chronic diseases. Persister bacteria are a subpopulation of physiological variants that becomes highly tolerant to antibiotics. Membrane...
5.
Low J, de Alwis R, Chen S, Kalimuddin S, Leong Y, Mah T, et al.
NPJ Vaccines
. 2022 Dec;
7(1):161.
PMID: 36513697
Coronavirus disease-19 (Covid-19) pandemic have demonstrated the importantance of vaccines in disease prevention. Self-amplifying mRNA vaccines could be another option for disease prevention if demonstrated to be safe and immunogenic....
6.
Ong E, Yee J, Ooi J, Syenina A, de Alwis R, Chen S, et al.
NPJ Vaccines
. 2022 Nov;
7(1):154.
PMID: 36443317
Remarkable potency has been demonstrated for mRNA vaccines in reducing the global burden of the ongoing COVID-19 pandemic. An alternative form of the mRNA vaccine is the self-amplifying mRNA (sa-mRNA)...
7.
Syenina A, Gan E, Toh J, de Alwis R, Lin L, Tham C, et al.
PLoS Biol
. 2022 May;
20(5):e3001643.
PMID: 35639676
Ensuring high vaccination and even booster vaccination coverage is critical in preventing severe Coronavirus Disease 2019 (COVID-19). Among the various COVID-19 vaccines currently in use, the mRNA vaccines have shown...
8.
Kalimuddin S, Tham C, Qui M, de Alwis R, Sim J, Lim J, et al.
Med
. 2021 Apr;
2(6):682-688.e4.
PMID: 33851143
Background: RNA vaccines against coronavirus disease 2019 (COVID-19) have demonstrated ∼95% efficacy in phase III clinical trials. Although complete vaccination consisted of 2 doses, the onset of protection for both...